Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort 2025-01-02
  2. Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS) 2024-04-16
  3. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China 2021-10-27

Studies

4 studies carry this tag.

Date range

2018 to 2025

Top journals

  • Alzheimer's research & therapy 2
  • Frontiers in aging neuroscience 1
  • Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma phospho-tau217 as a predictive biomarker for Alzheimer's disease in a large south American cohort

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Alzheimer's research & therapy 2025-01-02 Biomarkers

    Most investigations have previously focused on highly selected cohorts with established AD-endophenotypes (CSF biomarkers, autopsy report, PET etc.), while data on cohorts with clinical assessment are currently lacking, especially in non-European populations.

  2. Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS)

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's research & therapy 2024-04-16 Brain scans and imaging

    The GHABS cohort may provide helpful guidance toward designing standard AD community cohorts in South China.

  3. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. Frontiers in aging neuroscience 2021-10-27 Biomarkers

    After adjusting for age, sex, and the apolipoprotein E ( APOE ) alleles, compared to the CN group, the plasma t-tau, and NfL were significantly increased in the AD group ( p < 0.01, Bonferroni correction).

  4. Seizure frequency and risk of cognitive impairment in people living with epilepsy in a sub-urban community in South Eastern Nigeria

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018-11-13 Cognitive tests and assessment

    This study is aimed at assessing the impact of seizure frequency on the cognitive performance of epileptic adult patients in a rural community in South Eastern Nigeria.

All topic tags with their study counts